CK Life Sciences International Holdings Inc
00775
Company Profile
Business description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D. The company derives maximum revenue from the Nutraceutical segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.
Contact
2 Dai Fu Street
Tai Po Industrial Estate
Tai Po
Hong Kong
HKGT: +852 21261212
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,935
Stocks News & Analysis
stocks
Chart of the Week: We see opportunity in Mineral Resources despite debt concerns
Shares trade at a discount despite attractive longer-term outlook.
stocks
The ultimate investing hack: dividend growth stocks
Finding companies built for lasting dividend growth.
stocks
Is the data centre party over for Goodman?
Global spending spree on data centres could mean a declining return on invested capital.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,899.20 | 17.30 | -0.19% |
| CAC 40 | 8,087.42 | 12.81 | 0.16% |
| DAX 40 | 23,693.71 | 17.15 | -0.07% |
| Dow JONES (US) | 47,882.90 | 408.44 | 0.86% |
| FTSE 100 | 9,692.07 | 9.73 | -0.10% |
| HKSE | 25,760.73 | 334.32 | -1.28% |
| NASDAQ | 23,454.09 | 40.42 | 0.17% |
| Nikkei 225 | 49,864.68 | 561.23 | 1.14% |
| NZX 50 Index | 13,507.02 | 75.52 | -0.56% |
| S&P 500 | 6,849.72 | 20.35 | 0.30% |
| S&P/ASX 200 | 8,602.60 | 16.20 | -0.19% |
| SSE Composite Index | 3,878.00 | 19.71 | -0.51% |